A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

Trial Profile

A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Bupivacaine/meloxicam (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Heron Therapeutics
  • Most Recent Events

    • 26 Sep 2017 Status changed from recruiting to completed.
    • 31 Mar 2017 Planned number of patients changed from 500 to 550.
    • 31 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top